Elanco Animal Health Incorporated (NYSE: ELAN) announced Wednesday that the company has received unanimous approval from the U.S. Federal Trade Commission (FTC) for its acquisition of Bayer Animal Health, a division of Bayer AG (ETR: BAYN). The FTC decision represents the final antitrust clearance needed to complete the transaction, which continues on track for closing at the beginning of August.
Read the full article: Elanco Receives U.S. Federal Trade Commission Approval for Acquisition of Bayer Animal Health //
Source: https://www.businesswire.com/news/home/20200715005638/en/Elanco-Receives-U.S.-Federal-Trade-Commission-Approval